Automatic detection of Alzheimer’s disease (AD) from spontaneous speech has reached high accuracy, but the strongest systems fine-tune large language models and transmit raw patient audio or transcripts to third-party cloud services. These dependencies raise privacy and de ployment barriers that limit screening at the point of care. We present a privacy-preserving pipeline that uses frozen self-supervised speech representations (wav2vec2) with a compact attention classifier, without fine-tuning the encoder or transmitting audio or transcripts because the encoder is frozen, the pipeline avoids the principal computational cost of competing systems, which fine-tune models with hundreds of millions of parameters: we train only the compact downstream classifier (337,409 parameters), roughly three orders of magnitude fewer trainable parameters than fine-tuning the ∼300M-parameter encoder. All processing runs locally, and no audio or transcript is transmitted to third-party services. On the ADReSSo 2021 benchmark, the compact classifier reaches a held-out test AUC of 0.821 ± 0.023 and an accuracy of 0.755 ± 0.008 (mean and standard deviation across five independently trained models), comparable to a classical support vector machine baseline (0.761 accuracy, 0.788 AUC) and to the official challenge baseline (0.789 accuracy, 0.781 AUC). The classifier quantizes to INT8 with no measurable change in test performance, reducing model size from 1.35 to 0.35 MB, and runs in 2.3 ms on a single CPU thread. To examine whether the representations themselves carry identifying information, we conduct a recording-session re-identification analysis. Recording session identifiability, which may reflect speaker, channel, microphone, and session cues, is reduced by more than 10× from raw acoustic features to the processed representations, while diagnostic signal is retained. The evaluation uses a single public dataset and does not include clinical validation, which we state as a limitation. The pipeline’s accuracy is within roughly 3 percentage points of the official challenge baseline (0.755 versus 0.789), a small cost in exchange for avoiding both fine-tuning and third-party data transmission.
Electrochemical sensor arrays that perform simultaneous multi-technique (SMT) measurements within a shared electrolyte are essential for continuous, multi-analyte detection in microfluidic platforms for environmental and healthcare monitoring. This review examines the potentiostat architectures and electrode geometries relevant to SMT operation. Traditional single channel and multi-electrode potentiostat topologies are surveyed, and their suitability for multi-cell shared-electrolyte environments is evaluated. Additionally, crosstalk mechanisms in shared electrolytes are classified into chemical, electrical, and a newly identified category termed stability-based interference, which arises from conflicting feedback loops in conventional grounded working electrode instrumentation. A survey of existing multi-cell platforms reveals that most reported systems either avoid true SMT operation or address crosstalk primarily through electrode geometry without systematic evaluation of instrumentation effects. Based on this analysis, we introduce an instrumentation and electrode geometry co-design framework that provides a unified design pathway toward continuous multi-analyte microfluidic sensors for wearable and point-of-care applications.